ArticleGigaScience2026
Cord blood DNA methylation and cell-type composition are not significantly associated with severe preeclampsia after cell-type and clinical covariate adjustment.
Article in GigaScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Placental molecular subtypes of severe preeclampsia reveal divergent aging trajectories and fetal growth outcomes.medRxiv : the preprint server for health sciences · 2026Article
- Cord blood DNA methylation and cell-type composition are not significantly associated with severe preeclampsia after cell-type and clinical covariate adjustment.GigaScience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundPreeclampsia is a severe pregnancy complication that threatens maternal and neonatal health and well-being. Previous studies on epigenome-wide association studies (EWAS) of preeclampsia produced inconsistent results in cord blood tissues, and one possible explanation is their failure to rigorously adjust for cell proportions, gestational age, or other necessary variables.
methodsHere, we calculated the DNA methylation changes in cord blood from newborns affected by preeclampsia, using a multi-ethnic cohort from the Hawaii population (24 cases, 38 controls). We comprehensively adjusted for variables, such as maternal age, body mass index, and parity, and estimated the cell proportions. We also re-analyzed 2 previous datasets with adjustments to estimated cell proportions and conducted a pooled analysis by merging all 3 datasets together to increase the statistical power (58 cases, 71 controls). Lastly, we included idiopathic preterm (preterm delivery with no known reasons) cord blood samples (n = 11) to disentangle the effect of severe preeclampsia and small gestational age.
resultsWe showed that after adjusting cell-type proportions and patient clinical characteristics, most of the so-called statistically significant CpG methylation changes associated with severe preeclampsia disappeared in our own data, 2 public datasets, and the pooled analysis combining all 3 datasets. This result still holds after including idiopathic preterm samples in the control group. Rather, we found that gestation progression is accompanied by statistically significant proportion changes in several cell types, such as granulocytes, nucleated red blood cells (nRBCs), CD8T cells, and B cells, which contribute to most DNA methylation differences between case and control groups. Preeclampsia has interactions on cell proportion changes in granulocytes, monocytes, and nRBCs.
conclusionsIn summary, our study shows that the previously reported differentially methylated patterns in cord blood are actually artifacts due to not properly adjusting for cell-type heterogeneity, gestational age, and clinical covariates. Severe preeclampsia is not associated with statistically significant DNA methylation changes but changes in cell proportion. This finding alerts to the scientific rigor needed in EWAS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.